Tafenoquine — a radical improvement?

Tafenoquine — a radical improvement?

Bibliographic Details
Main Author:	White, N
Format:	Journal article
Language:	English
Published:	Massachusetts Medical Society 2019

Similar Items

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
by: Watson, J, et al.
Published: (2018)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
by: James Watson, et al.
Published: (2018-04-01)

The antimalarial activity of tafenoquine in falciparum malaria
by: White, NJ
Published: (2023)

Tafenoquine for the prevention of Plasmodium vivax malaria relapse
by: Watson, JA, et al.
Published: (2021)

Tafenoquine for the prevention of Plasmodium vivax malaria relapse
by: James A Watson, et al.
Published: (2021-05-01)

Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency
by: Commons, RJ, et al.
Published: (2020)

Safety and Efficacy of Tafenoquine for Plasmodium vivax Malaria Prophylaxis and Radical Cure: Overview and Perspectives
by: Markus MB
Published: (2021-09-01)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
by: James A Watson, et al.
Published: (2022-12-01)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis
by: Watson, JA, et al.
Published: (2022)

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
by: James A Watson, et al.
Published: (2024-02-01)

Tafenoquine for children: a step towards implementation
by: Commons, RJ, et al.
Published: (2021)

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis'
by: Watson, JA, et al.
Published: (2024)

Radical curative efficacy of tafenoquine combination regimens in <it>Plasmodium cynomolgi</it>-infected Rhesus monkeys (<it>Macaca mulatta</it>)
by: Kenworthy David, et al.
Published: (2011-07-01)

Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study
by: Geoffrey W. Birrell, et al.
Published: (2022-11-01)

Tafenoquine for travelers' malaria: evidence, rationale and recommendations
by: Baird, J
Published: (2018)

Repurposing of the antimalarial agent tafenoquine to combat MRSA
by: Pengfei She, et al.
Published: (2023-12-01)

Comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
by: Raman Sharma, et al.
Published: (2024-02-01)

Tafenoquine and G6PD: a primer for clinicians
by: Chu, CS, et al.
Published: (2019)

Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria
by: Lacerda, MVG, et al.
Published: (2019)

Tafenoquine versus primaquine to prevent relapse of plasmodium vivax malaria
by: Watson, J, et al.
Published: (2019)

Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria
by: Llanos-Cuentas, A, et al.
Published: (2019)

Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria
by: St Jean, PL, et al.
Published: (2020)

Pharmacokinetic Models of Tafenoquine: Insights for Optimal Malaria Treatment Strategies
by: Luisa Oliveira Santos, et al.
Published: (2024-08-01)

Determination of tafenoquine in dried blood spots and plasma using LC and fluorescence detection.
by: Römsing, S, et al.
Published: (2011)

Determination of tafenoquine in dried blood spots and plasma using LC and fluorescence detection
by: Romsing, S, et al.
Published: (2011)

Single loading-dose tafenoquine for malaria chemoprophylaxis during brief travel?
by: Baird, JK
Published: (2021)

Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review
by: Stephan Duparc, et al.
Published: (2020-03-01)

Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria
by: Raman Sharma, et al.
Published: (2024-05-01)

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
by: Ebstie YA, et al.
Published: (2016-07-01)

Relapses of Plasmodium vivax malaria threaten disease elimination: time to deploy tafenoquine in India?
by: Amit Sharma, et al.
Published: (2021-02-01)

Activities of artesunate-based combinations and tafenoquine against Babesia bovis in vitro and Babesia microti in vivo
by: Leonardo J. M. Carvalho, et al.
Published: (2020-07-01)

Extended blood stage sensitivity profiles of Plasmodium cynomolgi to doxycycline and tafenoquine, as a model for Plasmodium vivax
by: Christensen, Peter, et al.
Published: (2024)

Use of tafenoquine to treat a patient with relapsing babesiosis with clinical and molecular evidence of resistance to azithromycin and atovaquone
by: Luis A. Marcos, et al.
Published: (2022-01-01)

Interactions between tafenoquine and artemisinin-combination therapy partner drug in asexual and sexual stage Plasmodium falciparum
by: Karen Kemirembe, et al.
Published: (2017-08-01)

Enantiomeric resolution of primaquine, quinacrine and tafenoquine antibacterial medicines using ristocetin macrocyclic glycopeptide antibiotics CSP
by: Zeid A. ALOthman, et al.
Published: (2020-01-01)

A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.
by: Hale, B, et al.
Published: (2003)

Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data
by: Hounkpatin AB, et al.
Published: (2019-03-01)

Efficacy Evaluation of 10-Hydroxy Chondrofoline and Tafenoquine against <i>Leishmania tropica</i> (HTD<sub>7</sub>)
by: Sayyed Ibrahim Shah, et al.
Published: (2022-08-01)

Failure of an Approximately Six Week Course of Tafenoquine to Completely Eradicate <i>Babesia microti</i> Infection in an Immunocompromised Patient
by: Prithiv J. Prasad, et al.
Published: (2022-09-01)

Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: A cost-effectiveness analysis using a transmission model.
by: David J Price, et al.
Published: (2024-01-01)